Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

PURPOSE: Specific activating mutations within the epidermal growth factor receptor (EGFR) identify a subset of non – small cell lung cancers with dramatic sensitivity to the specific tyrosine kinase inhibitors (TKI), gefitinib and erlotinib. Despite the abundant expression of EGFR protein in a broad...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kwak, Eunice L., Jankowski, Janusz, Thayer, Sarah P., Lauwers, Gregory Y., Brannigan, Brian W., Harris, Patricia L., Okimoto, Ross A., Haserlat, Sara M., Dris coll, David R., Ferry, David, Muir, Beth, Settleman, Jeff, Fuchs, Charles S., Kulke, Matthew H., Ryan, David P., Clark, Jeff W., Sgroi, Dennis C., Haber, Daniel A., Bell, Daphne W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2006
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3807136/
https://ncbi.nlm.nih.gov/pubmed/16857803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-06-0189
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi